Testing the 2022 optic neuritis diagnostic criteria
Part of Brain & nervous system, Eyes & vision clinical trials.
This study is checking whether a new 2022 set of diagnostic rules correctly identifies optic neuritis, which is inflammation of the nerve that connects your eye to your brain. If you've recently had vision problems and doctors suspect this condition, participating could help confirm the diagnosis and shape future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be having new or worsening vision problems in one or both eyes right now.
- The vision problems must have started within the last 90 days.
- Your doctor must think optic neuritis (inflammation of the nerve that connects your eye to your brain) is one possible cause.
- You cannot have been in this study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the eye-to-brain visual pathways work in people who have had optic neuritis symptoms for less than 4 weeks. It may help researchers better understand neuro-inflammatory (nerve inflammation) disorders and improve future care.
This study uses a new type of MRI to look at the optic nerve in people who have recently had optic neuritis (inflammation of the nerve that connects the eye to the brain). The goal is to see if this MRI can give doctors better information about the condition, which may help guide treatment.
This study tests whether a new medication called privosegtor can help restore vision in people who recently experienced sudden vision loss in one eye due to optic nerve inflammation. You would receive the study drug early after your symptoms start, when treatment may be most effective.
This study aims to create a tool that helps predict how well people may recover after optic neuritis (inflammation of the optic nerve that can affect vision). By participating, you can help doctors better understand and forecast outcomes for future patients.
This Phase 2 trial tests whether clemastine can help regrow the protective covering around the optic nerve after acute optic neuritis (an inflammation-related vision problem). It may help improve vision recovery and signal how well “remyelination” happens.
This study uses a special MRI scan while you rest to look for brain and eye signals that may relate to recovery in people with suspected optic neuritis. If you’re eligible, it may help researchers better understand what predicts vision improvement.
Hear when a new Optic Neuritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.